InsidersTradesSigma
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
Browse the detailed record of transactions filed by Kelly Timothy P, 管理人员. Officer active across 2 companies, notably Homology Medicines, Inc.. Aggregated, 6 filings have been published. Split: 0 buy · 3 sells. Total volume traded: €68k. Activity tracked since 1 March 2021. The latest transaction was disclosed on 25 February 2026 (Cession). Regulator: SEC (Form 4). The full history is openly available.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
6 条申报中的 6 条
Kelly Timothy P is an Executive at Homology Medicines, Inc. While his specific role is noted as 'See Remarks', he contributes to the leadership and strategy of the company. His expertise is essential for guiding Homology in developing innovative therapeutic solutions.